Hantech Bio-Technology Co (ROCO:1294) ROE %: 18.49% (As of Dec. 2025) — 14% Below Median


ROCO:1294 Hantech Bio-Technology Co Ltd ROCO:1294
74 GF Score
Price NT$62.00
GF Value NT$76.67
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hantech Bio-Technology Co ROE %?

Hantech Bio-Technology Co ROCO:1294 -6.42% 74 ROE % is 18.49% as of Dec. 2025, which is 14% below its 10-year median of 21.50. GuruFocus rates ROCO:1294 with a GF Score™ of 74/100 and a GF Value™ of NT$76.67 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,913 Consumer Packaged Goods companies, Hantech Bio-Technology Co ranks better than 80.82% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Hantech Bio-Technology Co's annualized net income for the quarter that ended in Dec. 2025 was NT$149.9 Mil. Hantech Bio-Technology Co's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was NT$810.4 Mil. Therefore, Hantech Bio-Technology Co's annualized ROE % for the quarter that ended in Dec. 2025 was 18.49%.

The historical rank and industry rank for Hantech Bio-Technology Co's ROE % or its related term are showing as below:

ROCO:1294' s ROE % Range Over the Past 10 Years
Min: 9.57   Med: 21.5   Max: 49.39
Current: 17.12

During the past 7 years, Hantech Bio-Technology Co's highest ROE % was 49.39%. The lowest was 9.57%. And the median was 21.50%.

ROCO:1294's ROE % is ranked better than
80.82% of 1913 companies
in the Consumer Packaged Goods industry
Industry Median: 6.71 vs ROCO:1294: 17.12

Hantech Bio-Technology Co  (ROCO:1294) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=149.864/810.4485
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(149.864 / 854.908)*(854.908 / 1128.4805)*(1128.4805 / 810.4485)
=Net Margin %*Asset Turnover*Equity Multiplier
=17.53 %*0.7576*1.3924
=ROA %*Equity Multiplier
=13.28 %*1.3924
=18.49 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=149.864/810.4485
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (149.864 / 187.32) * (187.32 / 187.828) * (187.828 / 854.908) * (854.908 / 1128.4805) * (1128.4805 / 810.4485)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8 * 0.9973 * 21.97 % * 0.7576 * 1.3924
=18.49 %

Note: The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Hantech Bio-Technology Co ROE % Related Terms


Hantech Bio-Technology Co ROE % Historical Data

* Premium members only.

The historical data trend for Hantech Bio-Technology Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hantech Bio-Technology Co ROE % Chart

Hantech Bio-Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial 20.52 21.50 44.55 25.61 16.89

Hantech Bio-Technology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.37 15.69 19.03 15.50 18.49

ROCO:1294 vs KHC, GIS: ROE % Comparison

For the Packaged Foods subindustry, Hantech Bio-Technology Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hantech Bio-Technology Co ROE % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hantech Bio-Technology Co's ROE % distribution charts can be found below:

* The bar in red indicates where Hantech Bio-Technology Co's ROE % falls into.


ROCO:1294
74GF Score
Hantech Bio-Technology Co Ltd ROCO:1294
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hantech Bio-Technology Co ROE % Calculation

Hantech Bio-Technology Co's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=139.052/( (817.779+829.164)/ 2 )
=139.052/823.4715
=16.89 %

Hantech Bio-Technology Co's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Sep. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=149.864/( (791.733+829.164)/ 2 )
=149.864/810.4485
=18.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 18.49% mean?
Hantech Bio-Technology Co (ROCO:1294) has a ROE % of 18.49% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Hantech Bio-Technology Co and its competitors. This is 14% below median its historical median of 21.50. Over the past decade, Hantech Bio-Technology Co's ROE % has ranged from 9.57 to 49.39. According to the industry distribution chart, Hantech Bio-Technology Co ranks #367 out of 1913 companies in the Consumer Packaged Goods industry, placing it in the top 19.2%.
Is Hantech Bio-Technology Co's ROE % too high?
Hantech Bio-Technology Co's current ROE % of 18.49% is 14% below median its 10-year median of 21.50. Over the past 10 years, this metric has ranged from a low of 9.57 to a high of 49.39. The Consumer Packaged Goods industry median ROE % is 6.71. Hantech Bio-Technology Co's value of 18.49% is 175.6% above this industry median. Based on the distribution chart, Hantech Bio-Technology Co ranks #367 out of 1913 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Hantech Bio-Technology Co has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hantech Bio-Technology Co's ROE % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hantech Bio-Technology Co ranks #367 out of 1913 companies for ROE %. This places Hantech Bio-Technology Co in the top 19% of its industry — outperforming the majority of peers. The industry median ROE % is 6.71. Hantech Bio-Technology Co's value of 18.49% is 175.6% above this benchmark. Historically, Hantech Bio-Technology Co's own ROE % has ranged from 9.57 to 49.39 over the past decade. While the company's 10-year median is 21.50 vs. the industry median of 6.71, Hantech Bio-Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Consumer Packaged Goods company?
The median ROE % among Consumer Packaged Goods companies is 6.71, based on 1,913 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hantech Bio-Technology Co's current ROE % of 18.49% is 175.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Hantech Bio-Technology Co and its competitors. For the Consumer Packaged Goods industry, the median ROE % is 6.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hantech Bio-Technology Co's current ROE % is 18.49%, which is 14% below median its own 10-year median of 21.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hantech Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Hantech Bio-Technology Co (ROCO:1294) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$76.67, compared to a current price of NT$62.00 — trading 19.1% below its estimated fair value. The current ROE % is 18.49%, which is 14% below median its 10-year median of 21.50 and 175.6% above the Consumer Packaged Goods industry median of 6.71. Hantech Bio-Technology Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Hantech Bio-Technology Co (ROCO:1294), the current ROE % is 18.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hantech Bio-Technology Co (ROCO:1294) Overvalued in 2026?

Based on GuruFocus' analysis, Hantech Bio-Technology Co stock appears to be undervalued. The current stock price of NT$62.00 is trading 19.1% below its estimated GF Value™ of NT$76.67. GuruFocus considers Hantech Bio-Technology Co to be Modestly Undervalued.

Key valuation signals for ROCO:1294:

  • ROE %: 18.49% (14% below median its 10-year median of 21.50)
  • GF Value™: NT$76.67 vs. price of NT$62.00 (19.1% below fair value)
  • GF Score™: 74/100 with 3 warning signs
  • Industry Position: 175.6% above the Consumer Packaged Goods median (#367 of 1913)

No single metric tells the full story. See the ROCO:1294 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hantech Bio-Technology Co Business Description

Address No. 101, Gongye Road, Xihu Township, Changhua, TWN, 514
Hantech Bio-Technology Co Ltd mainly engaged in the manufacture, trading, and agency of biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products.
74GF Score

Get the complete analysis for ROCO:1294

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$62.00
Price
NT$76.67
GF Value